Path ID: DB09389_MESH_D015663_1
Concepts
| Identifier | Name | Type |
|---|---|---|
| MESH:D009644 | Norgestrel | Drug |
| MESH:D015663 | Postmenopausal osteoporosis | Disease |
Relationships
NOTE: predicates are annotated in Biolink Model (v1.3.0)
| Subject | Predicate | Object |
|---|---|---|
| Norgestrel | TREATS | Postmenopausal Osteoporosis |
Comment: Norgestrel is composed of a racemic mixture of two stereoisomers, dextronorgestrel and levonorgestrel. However, only the levorotary enantiomer (levonorgestrel) is biologically active. Norgestrel is prescribed in combination with estradiol as a hormone therapy during menopause to prevent osteoporosis and in this case estradiol is the acive drug that prevents oseoporosis, while norgestrel is added for the protection of the endometrium
Reference: